Liu Mingsu, Li Guangqin, Tang Jie, Liao Yan, Li Lin, Zheng Yang, Guo Tongli, Kang Xin, Yuan Maoting
Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Clin Neurol. 2018 Apr;14(2):141-152. doi: 10.3988/jcn.2018.14.2.141.
There is increasing recognition of the importance of stroke in females to both clinical and public health. The natural course of stroke is worse in females than in males, but the evidence regarding sex disparities in the responses to thrombolysis in stroke patents is still controversial. We compared outcomes after thrombolysis treatment between females and males.
Clinical trials reported in the Embase, PubMed, and Cochrane Library electronic databases up to March 13, 2017 were included in this analysis. Two reviewers independently extracted the data and conducted quality assessments. Statistical tests were performed to check for heterogeneity and publication bias. Sensitivity analysis was also performed to evaluate the stability of the conclusions.
Sixteen reports involving 60,159 patients were available for analysis. The female patients were a 0.89-fold [95% confidence interval (CI)=0.87-0.90, p<0.001], 0.89-fold (95% CI=0.87-0.91, p<0.001), and 1.24-fold (95% CI=1.11-1.36, p<0.001) more likely to obtain good, excellent, and poor functional outcomes, respectively, with no significant difference in the complications of symptomatic intracranial hemorrhage among the sexes [risk ratios (RR)=0.99, 95% CI=0.92-1.07, p=0.81] after thrombolysis treatment. In addition, the prevalence of a good functional outcome did not differ significantly between females and males in the intra-arterial thrombolysis (IAT) group (RR=1.05, 95% CI=0.85-1.29, p=0.67) in a subgroup analysis.
This study has demonstrated that females often exhibit a worse outcome than males after intravenous thrombolysis (IVT), whereas no relevant sex differences were found in outcome or recanalization after IAT, with safety regarding hemorrhage complications from thrombolysis being the same for the sexes. However, IVT should not be withheld from female stroke patients solely based on their sex before the findings are confirmed in further large-scale research.
中风对女性临床和公共卫生的重要性日益受到认可。中风的自然病程在女性中比男性更严重,但关于中风患者溶栓反应中性别差异的证据仍存在争议。我们比较了女性和男性溶栓治疗后的结果。
纳入截至2017年3月13日在Embase、PubMed和Cochrane图书馆电子数据库中报告的临床试验。两名研究者独立提取数据并进行质量评估。进行统计检验以检查异质性和发表偏倚。还进行了敏感性分析以评估结论的稳定性。
有16份报告涉及60159例患者可供分析。女性患者获得良好、优秀和差的功能结局的可能性分别高出0.89倍[95%置信区间(CI)=0.87 - 0.90,p<0.001]、0.89倍(95%CI = 0.87 - 0.91,p<0.001)和1.24倍(95%CI = 1.11 - 1.36,p<0.001),溶栓治疗后有症状性颅内出血的并发症在性别之间无显著差异[风险比(RR)= 0.99,95%CI = 0.92 - 1.07,p = 0.81]。此外,在亚组分析中,动脉内溶栓(IAT)组中女性和男性良好功能结局的患病率无显著差异(RR = 1.05,95%CI = 0.85 - 1.29,p = 0.67)。
本研究表明,静脉溶栓(IVT)后女性的结局通常比男性差,而IAT后在结局或再通方面未发现相关性别差异,溶栓出血并发症的安全性在性别上相同。然而,在进一步大规模研究证实这些发现之前,不应仅基于性别而不给女性中风患者进行IVT治疗。